This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks. US ...
New strategic partnership delivers first-of-its-kind benchmark intelligence and negotiation power to 3,800+ members CoreTrust, a leading Group Purchasing Organization (GPO) trusted by over 3,800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results